-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Neuphoria Therapeutics Inc. quarterly and annual Nonoperating Income (Expense) history and change rate from 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $-4,288,608, a 263% decline year-over-year.
- Neuphoria Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $-6,628,268, a 233% decline year-over-year.
- Neuphoria Therapeutics Inc. annual Nonoperating Income (Expense) for 2025 was $291,093, a 87.4% decline from 2024.
- Neuphoria Therapeutics Inc. annual Nonoperating Income (Expense) for 2024 was $2,312,890, a 400% increase from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)